TOP NEWS

JenaValve Technology Names VP

Irvine-based heart valve developer JenaValve said Thursday that it has named a new executive, appointing Janet M. Fauls as the company's new Vice President of Regulatory Affairs. Fauls was most recently Vice President of Global Regulatory Affairs for Endologix. JenaValve is venture backed by Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management, Omega Funds, RMM, Sunstone Capital, Valiance and VI Partners.